@article{ref1,
title="Cannabis legalization and cannabis-related hospitalizations in Ontario, Canada",
journal="Canadian journal of psychiatry, The",
year="2022",
author="Kim, Chungah and Chum, Antony and Nielsen, Andrew and Macmaster, Frank and Rittenbach, Katherine and Allin, Sara and O'Campo, Patricia and Kirst, Maritt and Hamilton, Hayley",
volume="ePub",
number="ePub",
pages="ePub-ePub",
abstract="Canada legalized recreational cannabis on October 17, 2018. Since then, only one Canadian study (in Quebec) examined the impact of legalization on cannabis-related hospitalizations.&quot; That study focused on youth (0-19) using 5.5 months of post-legalization data, which precluded understanding the impact on trends over a longer period after legalization. While a number of recent studies have examined the impact of legalization on cannabis-related emergency department (ED) visits in Canada, 23 cannabis-related hospitalizations should not be ignored since substance-relate in-patient care is required in the most severe spectrum of cases and they contribute to significant healthcare costs.  The multi-phased approach of cannabis legalization in Ontario provides an opportunity to examine the impact of the different phases of cannabis sales regulation on cannabis-related hospitalizations. The Ontario legal cannabis availability approach involves a hybrid model of government operated online sales and licensed private retail stores.  Implementation of the model was phased, with Phase 1 of legalization (October 2018-March 2020) associated with flower and herb sales online and limited private retail ...<p /> <p>Language: en</p>",
language="en",
issn="0706-7437",
doi="10.1177/07067437221114785",
url="http://dx.doi.org/10.1177/07067437221114785"
}